Santos de Azevedo Juliana Monteiro has filed a Form 144 with the SEC, indicating plans to propose the sale of securities. This filing is significant as it may suggest a change in ownership or liquidity strategy for the company. Such moves can impact investor confidence and market dynamics.
The company, Santos de Azevedo Juliana Monteiro, is categorized under the entity type 'other' and does not have a specific SIC description or ticker listed. The recent filing was made on October 26, 2026, and is part of a series of filings that include other forms such as Form 4.
The filing states, "Report of proposed sale of securities," which implies that the company is taking steps to manage its securities actively. Details were not available in the SEC filing regarding the specifics of the securities being sold or the reasons behind the proposed sale.
This development may affect various stakeholders, including investors and market analysts, as they assess the implications of this proposed sale. The filing does not specify what happens next, leaving the market to speculate on the potential outcomes.
Filing Details
The Form 144 filing was accepted on the same day it was submitted, October 26, 2026, at 15:10:02. This prompt acceptance indicates that the SEC has acknowledged the filing without any immediate issues.
In terms of documentation, the filing includes a primary document, which is available in both HTML and XML formats. The primary document is identified as 'primary_doc.xml' and has a size of 3,661 bytes. Additionally, a complete submission text file is provided, which can be accessed as '0000080424-26-000262.txt' and has a size of 5,218 bytes.
Company Information
Santos de Azevedo Juliana Monteiro is linked to Procter & Gamble Co, which is identified by the Central Index Key (CIK) number 0000080424. The company is incorporated in Ohio and has a fiscal year ending on June 30. Its IRS number is 310411980, and it operates under the Standard Industrial Code (SIC) 2840, which pertains to soap, detergents, cleaning preparations, perfumes, and cosmetics.
The filing does not provide specific details on the number of shares intended for sale or the potential impact on the company's capital structure.